# Celularity (CELU) — News

CELU · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/celu/news

## Recent headlines

- [Trading released/resumed: (NXGL) Reason not available](https://www.ainvest.com/news/trading-released-resumed-nxgl-reason-2610-75) — AInvest Wire, Oct 14, 2026
  Trading in shares of NexGel, Inc. (NXGL) was temporarily suspended and has since resumed, according to recent market updates. No specific reason for the suspension was disclosed at this time. Investors are advised to monitor official announcements from the company or the relevant exchange for…
- [Celularity announces Naveen Jain to join board of directors](https://www.ainvest.com/news/celularity-announces-naveen-jain-join-board-directors-2609) — AInvest Wire, Sep 29, 2026
- [Cellularity provides update regarding Nasdaq listing compliance](https://www.ainvest.com/news/cellularity-update-nasdaq-listing-compliance-2608) — AInvest Wire, Aug 25, 2026
  Celularity Inc. (Nasdaq: CELU) has regained compliance with Nasdaq Listing Rule 5250(c)(1) following the timely filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The company submitted the report on April 30, 2026, and received confirmation from Nasdaq on May 1,…
- [Sanuwave Health - market disruption impacting Ultramist system sales](https://www.ainvest.com/news/sanuwave-health-market-disruption-impacting-ultramist-system-sales-2606) — AInvest Wire, Jun 16, 2026
  Celularity, Inc. has completed the sale of its UltraMIST® Ultrasound Healing Therapy asset to Sanuwave Health, Inc. [OTC PINK: SNWV], granting Sanuwave partnership rights to Celularity’s wound care biologic product portfolio. This transaction aligns with Celularity’s strategic focus on surgical…
- **Important** — [Celularity files to sell 6.52 million shares of Class A common stock for holders](https://www.ainvest.com/news/celularity-files-sell-6-52-million-shares-class-common-stock-holders-2501) — AInvest Wire, Jan 30, 2025
  Celularity files to sell 6.52 million shares of Class A common stock for holders Celularity, Inc. (Nasdaq: CELU), a leading biotechnology company specializing in placental-derived allogeneic cell therapies and biomaterial products, recently announced a registered direct offering of 8,571,428 shares…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).